• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Androgen receptor coregulators in prostate cancer: mechanisms and clinical implications.

作者信息

Rahman Mujib, Miyamoto Hiroshi, Chang Chawnshang

机构信息

George Whipple Laboratory for Cancer Research, Department of Biochemistry, and the Cancer Center, University of Rochester Medical Center, Rochester, New York 14642, USA.

出版信息

Clin Cancer Res. 2004 Apr 1;10(7):2208-19. doi: 10.1158/1078-0432.ccr-0746-3.

DOI:10.1158/1078-0432.ccr-0746-3
PMID:15073094
Abstract
摘要

相似文献

1
Androgen receptor coregulators in prostate cancer: mechanisms and clinical implications.
Clin Cancer Res. 2004 Apr 1;10(7):2208-19. doi: 10.1158/1078-0432.ccr-0746-3.
2
Expression of androgen receptor coregulators in prostate cancer.雄激素受体共调节因子在前列腺癌中的表达
Clin Cancer Res. 2004 Feb 1;10(3):1032-40. doi: 10.1158/1078-0432.ccr-0990-3.
3
Functional Studies on Steroid Receptors.类固醇受体的功能研究
Methods Mol Biol. 2018;1786:117-130. doi: 10.1007/978-1-4939-7845-8_7.
4
Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.活化的Cdc42相关激酶Ack1通过雄激素受体酪氨酸磷酸化促进前列腺癌进展。
Proc Natl Acad Sci U S A. 2007 May 15;104(20):8438-43. doi: 10.1073/pnas.0700420104. Epub 2007 May 9.
5
Transition to androgen-independence in prostate cancer.前列腺癌向雄激素非依赖状态的转变。
J Steroid Biochem Mol Biol. 2002 Jul;81(3):191-201. doi: 10.1016/s0960-0760(02)00064-x.
6
The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression.雄激素受体负向调节c-Met的表达：对前列腺癌进展新机制的启示。
Cancer Res. 2007 Feb 1;67(3):967-75. doi: 10.1158/0008-5472.CAN-06-3552.
7
6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.6-(3,4-二氢异喹啉-2-基)-N-(6-甲氧基吡啶-2-基)烟酰胺-26(DIMN-26)通过诱导细胞凋亡和下调雄激素受体信号通路降低人前列腺癌细胞的增殖。
Chem Biol Interact. 2016 Dec 25;260:196-207. doi: 10.1016/j.cbi.2016.10.008. Epub 2016 Oct 5.
8
Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha.富含谷氨酰胺的小四肽重复序列蛋白α辅助伴侣蛋白对前列腺癌雄激素受体信号传导的调控
Cancer Res. 2007 Oct 15;67(20):10087-96. doi: 10.1158/0008-5472.CAN-07-1646.
9
[Recent trend in the development of novel treatments based on the mechanisms of prostate cancer progression].[基于前列腺癌进展机制的新型治疗方法的最新发展趋势]
Nihon Rinsho. 2016 May 20;74 Suppl 3:211-20.
10
Androgen receptors in early and castration resistant prostate cancer: friend or foe?早期及去势抵抗性前列腺癌中的雄激素受体：是友还是敌？
Hormones (Athens). 2013 Apr-Jun;12(2):224-35. doi: 10.14310/horm.2002.1406.

引用本文的文献

1
PROTAC technology for prostate cancer treatment.用于前列腺癌治疗的PROTAC技术。
Acta Mater Med. 2025 Jan 7;4(1):99-121. doi: 10.15212/amm-2024-0075. Epub 2025 Jan 30.
2
PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients.转移性去势初治前列腺癌患者单个循环肿瘤细胞的PSA分泌
Cancer Res Commun. 2025 Aug 1;5(8):1359-1371. doi: 10.1158/2767-9764.CRC-25-0158.
3
Phenotypic Plasticity and Androgen Receptor Bypass Drive Cross-Resistance to Apalutamide in Castration-Resistant Prostate Cancer Cell Models.
表型可塑性和雄激素受体旁路驱动去势抵抗性前列腺癌细胞模型对阿帕鲁胺的交叉耐药
Int J Mol Sci. 2025 Jun 20;26(13):5939. doi: 10.3390/ijms26135939.
4
Simulating androgen receptor selection in designer yeast.在定制酵母中模拟雄激素受体选择
Synth Syst Biotechnol. 2022 Aug 3;7(4):1108-1116. doi: 10.1016/j.synbio.2022.07.005. eCollection 2022 Dec.
5
AR-mTOR-SRF Axis Regulates HMMR Expression in Human Prostate Cancer Cells.AR-mTOR-SRF轴调控人前列腺癌细胞中HMMR的表达。
Biomol Ther (Seoul). 2021 Nov 1;29(6):667-677. doi: 10.4062/biomolther.2021.040.
6
Role of Testosterone Levels on the Combinatorial Effect of Extract and Enzalutamide on Androgen Dependent LNCaP Cells and in Patient Derived Cells.睾酮水平对提取物与恩杂鲁胺联合作用于雄激素依赖性 LNCaP 细胞及患者来源细胞的影响。
Integr Cancer Ther. 2021 Jan-Dec;20:1534735421996824. doi: 10.1177/1534735421996824.
7
Enzalutamide as an androgen receptor inhibitor prevents urothelial tumorigenesis.恩杂鲁胺作为一种雄激素受体抑制剂可预防尿路上皮肿瘤发生。
Am J Cancer Res. 2017 Oct 1;7(10):2041-2050. eCollection 2017.
8
Upregulation of heat shock protein 70 and the differential protein expression induced by tumor necrosis factor-alpha enhances migration and inhibits apoptosis of hepatocellular carcinoma cell HepG2.热休克蛋白70的上调以及肿瘤坏死因子-α诱导的差异蛋白表达增强了肝癌细胞HepG2的迁移并抑制其凋亡。
Int J Med Sci. 2017 Feb 25;14(3):284-293. doi: 10.7150/ijms.17861. eCollection 2017.
9
C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.C1QBP通过调控YBX1抑制雄激素受体（AR）增强的肾癌细胞侵袭。
Neoplasia. 2017 Feb;19(2):135-144. doi: 10.1016/j.neo.2016.12.003. Epub 2017 Jan 17.
10
Involvement of the Androgen and Glucocorticoid Receptors in Bladder Cancer.雄激素和糖皮质激素受体在膀胱癌中的作用
Int J Endocrinol. 2015;2015:384860. doi: 10.1155/2015/384860. Epub 2015 Aug 10.